Join Our Community:

Twitter  Linkedin  

Volume 03 Issue 29

August 19, 2022

Because life depends on us™
BSMA Clearing House
for latest news and information
...at a glance
ORGANIZATION NEWS!

DHL Supply Chain expands its Life Sciences and Healthcare Campus in Florstadt, Germany


FDA approves one of the priciest new treatments of all time — bluebird's gene therapy for beta thalassemia


Bill & Melinda Gates Foundation doubles down on health partnership with South Korea — report


UPDATED: 'We have failed to fail': Merck gambles $250M cash on a next-gen approach to mRNA — after punting its big alliance with Moderna


Resilience collaborates with the Mayo Clinic to manufacture rare and complex disease drugs


You can add a colorful Australian mining tycoon to the list of billionaires betting on biotech


Carlyle finds its first big biotech bet after teaming with Abingworth


Illumina Helped the World Fight COVID-19. Now, CEO Francis deSouza Has Monkeypox in His Sights


Mount Sinai, Regeneron unveil plans to sequence and study 1M patients' genomes


Almac Group plans $65M expansion to Souderton campus, more than 350 new jobs in Montgomery County


UT Haslam’s Graduate Supply Chain Programs Climb to No. 1 in Premier Ranking


UT's Haslam Undergraduate Supply Chain Program Rises to No. 2 in Distinguished Gartner Ranking


First HK Tech Forum at CityU tackles major challenges in data science and AI


J&J to remove talc products from shelves worldwide, replacing with cornstarch-based portfolio

EXECUTIVE NEWS!

Moderna taps new CFO from PerkinElmer after former one-day CFO ousted


GSK lands first-ever UNICEF contract for malaria vaccine worth $170M


Squeezed by AstraZeneca/Daiichi Sankyo, biotech developing HER2 ADC switches CEO, launches pipeline review


What CBRE's newest executive, James Bennett, says about life-science demand


MindMed Strengthens Board with Appointment of Two New Independent Directors


BRIEF—Heavyweight of Nordic life sciences takes over at Umecrine Cognition


Kymanox Announces First Kymanox Executive Advisor: Fran DeGrazio

The Editorial

These 3 Healthcare Threats Will Do More Damage Than Covid-19


by Robert Pearl, M.D.Contributor, Forbes


For two years, the Covid-19 pandemic rattled financial markets, dominated news coverage and disrupted daily life in ways most Americans would never have predicted.

But now, in year three, the coronavirus has been downgraded to a persistent yet manageable threat—on par with the flu. Thanks to some familiar medical solutions (vaccines, antiviral meds and public safety measures), three-quarters of Americans say the worst of Covid-19 is behind us.

Now, a new disaster looms. American healthcare stands in direct path of the perfect storm.

Forecasting disaster

Doomsday predictions often prove wrong or overinflated. But, in 2004, a team of hurricane experts at Louisiana State University predicted “a catastrophe [is] right on the horizon.” They were right. Less than a year later, New Orleans was eleven feet under water. Hurricane Katrina killed 1,833 people and left thousands more homeless.

How did the researchers know Katrina was coming? Using data-


Read more...

INNOVATIONS!

Improving supply chain management with IoT technology


Could voice-analyzing AI improve mental healthcare? Ellipsis and Ceras are banking on it


Building The Next-Gen Tech Stack For Life Sciences


US$ 514M arranged for construction of BioMed Assembly Innovation Park in Boston


CHIPS and Science Act Neglects the Importance of IP Rights in Encouraging American Innovators


The latest big data news and articles - insideBIGDATA


University Of Massachusetts Amherst: The Bacteria Powering A Truly Green Revolution In Personal Electronics


The New Artificial Intelligence Supply Chain: Happiness Ecosystems(Blog Series #1)


The 24 best medical device innovations of 2022

INFRASTRACTURE

America promised to invest in its infrastructure. What's happened since then? (Rebroadcast)


All 50+ US State EV Infrastructure Deployment Plans Are Ready To Go


Murkowski Announces Over $57 Million in Additional Infrastructure Funding for Alaskan Communities


How the Inflation Reduction Act Measures Up


Congress must tackle infrastructure permitting reform

CHALLENGES & SOLUTIONS!

7 Challenges Supply Chain Managers Will Need to Address in 2023


The U.S. supply chain is now facing two trade hurdles


Antitrust + Competition Life Sciences Quarterly Update - Q2 2022


Identity crisis: The global supply chain is in chaos. Can you trust your botanicals’ authenticity?


Community Spirit and Patent Protection


The five hottest private biotech companies in San Diego


CRISPR offers genetic clues to Alzheimer's in brain's cleaning crew


HHS inspector general: NIH failed to verify clinical trial results were reported on time


[Herald Interview]Right time for Korean companies to partner with Lithuania in life-science sector: Vice-minister


Inflation, Supply Chain Headaches And Staffing Shortages: CEOs Talk About 'Big Picture' Challenges


How Fleet Managers Can Cut Costs As Gas Prices Surge


Inventory issues are hurting the bottom line. It’s time for a hybrid approach to supply chains


Chinese Exporters Bemoan Signs of Weakening Global Demand


Pharmaceutical Solid Dosage Contract Manufacturing Market to Witness Growth Acceleration | Abbott Laboratories, Catalent Pharma Solutions, Jubilant Life Sciences Limited


Could Boston Turn on Biotech?


How Brazil is becoming a more favourable jurisdiction for life sciences patentees

UPCOMING EVENTS:

~~~~~~~

BSMA Europe
In-Person Summit:
September 29, 2022

LOCATION:
Brussels, La Hulpe, Belgium




~~~~~~~

BSMA Africa Inaugural
In-Person Summit:
Oct. 31-Nov. 1, 2022

LOCATION:
Kigali, Rwanda
Editor:
Devendra Mishra
Executive Director & Co-Founder
BSMA
+1-818-224-1552
Editor:
Dotti Yells
VP, Marketing Technology
BSMA